Varma Mutual Pension Insurance Co Takes Position in Danaher Corporation $DHR

Varma Mutual Pension Insurance Co purchased a new stake in Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 102,726 shares of the conglomerate’s stock, valued at approximately $19,567,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new position in Danaher during the second quarter worth $10,492,520,000. Norges Bank acquired a new stake in shares of Danaher in the 4th quarter worth $2,177,106,000. Generation Investment Management LLP purchased a new position in shares of Danaher during the 2nd quarter worth $1,287,949,000. Flossbach Von Storch SE purchased a new position in shares of Danaher during the 2nd quarter worth $747,260,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Danaher during the 2nd quarter valued at about $712,875,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 1.6%

Shares of NYSE:DHR opened at $219.42 on Friday. The company has a market capitalization of $154.25 billion, a price-to-earnings ratio of 38.97, a PEG ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The business has a 50-day moving average price of $195.80 and a 200 day moving average price of $192.61. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.77 earnings per share. Sell-side analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on DHR shares. Royal Bank Of Canada upped their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. TD Cowen decreased their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Guggenheim dropped their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. HSBC cut their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Finally, Piper Sandler initiated coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.